產(chǎn)品編號 | bs-11993R |
英文名稱 | Rabbit Anti-Phospho-Serine antibody |
中文名稱 | 磷酸化絲氨酸抗體 |
別 名 | Phosphoserine; phospho-Ser; phospho Ser; pan phospho Ser; pan-phospho Ser; pS; p-S; pSER; p-SER; p-serine; pan p-serine. 泛絲氨酸磷酸化抗體; 泛絲氨酸磷酸化; 泛磷酸化絲氨酸; |
Specific References (2) | bs-11993R has been referenced in 2 publications.
[IF=6.6] Jiajia Li. et al. Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics. Cells-Basel. 2021 Sep;10(9):2225 WB ; Human.
[IF=3.88] Fu, Juanli, et al. "Tetrachlorobenzoquinone exerts neurological pro-inflammatory activity by promoting HMGB1 release, which induces TLR4 clustering within the lipid raft." Toxicological Sciences (2016): kfw124. WB ; Mouse.
|
|
產(chǎn)品類型 | 磷酸化抗體 小分子抗體 |
研究領域 | 腫瘤 神經(jīng)生物學 信號轉(zhuǎn)導 激酶和磷酸酶 新陳代謝 |
抗體來源 | Rabbit |
克隆類型 | Polyclonal |
交叉反應 | Human (predicted: Rat,Cow,Chicken,Dog,Goose,Monkey) |
產(chǎn)品應用 | WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
細胞定位 | 細胞漿 |
性 狀 | Liquid |
濃 度 | 1mg/ml |
免 疫 原 | KLH conjugated Phosphoserine |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產(chǎn)品介紹 |
Changes in the serine/threonine phosphorylation state of a protein in response to various external stimuli can have profound effects on cellular signal transduction, apoptosis and carcinogenesis. The reagents, including phosphorylated protein/peptides, antibodies against the phosphospecific amino acid, are important tools to explore the activation of serine, threonine or tyrosine containing proteins. An aberrant protein phosphorylation is a hallmark of human disease, and the enzymes, particularly protein kinases, which control protein phosphorylation are recognized as a major new drug target family. SWISS: N/A CAS: 407-41-0 |
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關于肽鏈的設計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |